Our Scientific Networks
We have conducted some of the largest, most significant infectious diseases and vaccines (IDV) clinical trials on record. When you partner with us, you can be confident in getting the patient recruitment and retention numbers and high-quality data you need for your clinical trial.
Our Scientific Networks
In 2014, Julius Clinical founded ReSViNET, which has been an independent foundation since 2018. Our partnership with them allows us to provide our clients with exceptional operational support for RSV clinical trials and observational studies.
On April 10th, 2025, we will organise the webinar: Real-World Evidence in Vaccine Safety: Methods, Challenges, and Opportunities in Multi-Database Studies Why Attend?Expert Insights: Learn from leading professionals in vaccine epidemiolog...
On October 26, we presented the webinar: Operational Expertise in Action: Unleashing the Potential of Decentralized Clinical TrialsDuring this webinar, our speaker and co-hosts, dived into Decentralized Clinical Trials and discuss the case stu...
On September 6, our partner ReSViNET presented the webinar: “RSV and Asthma”Prof Tina Hartert, MD, MPH shared her insights on RSV in relationship to asthma. Her study of almost two thousand children has identified that delay in early life ...
Explore our IDV capabilities, case studies, and other resources.
"*" indicates required fields
"*" indicates required fields